With increasing competition, the valuations of the Paras Pharma has gone up to Rs 3,250 crore in the last few days. Despite the high valuation of Paras, many companies are keen to acquire the companys OTC brands, said an industry analyst based in Mumbai. Meanwhile, FMCG major Jyothi Laboratories is in advanced talks with Bengal-based Safechem Industries(makers of Safed) to acquire its detergent brands. In essence, the Rs 1.2- lakh crore Indian FMCG industry will witness a spate of acquisitions in the next few months.
According to industry analysts, PGHHCL has been looking at acquisition opportunities in consumer health care space for quite some time. Paras Pharmas OITC brands will have a strategic fit in P&G health care portfolio which includes Vicks, said an analyst in Mumbai.
When contacted by FE, Tapan Buch, chief financial officer, P&G India, said: As per our company policy, we do not comment on strategy or future plans. Meanwhile, Emami a key contender for Paras Pharma has just got its boards approval to raise Rs 5,000 crore through debt and equity dilution-a clear signal that Emami is looking at a big ticket acquisition in the near future. In fact, the company has recently moved a special resolution in this regard. After its acquisition of Zandu Phrama two years ago, Emami is now keen to acquire controlling stake in Paras Pharma. Aditiya Agarwal, director of Emami, who is currently holidaying in Thailand, was reluctant to comment on his company acquisition plans.
Yet another FMCG major Marico is also in talks with Paras Pharma to acquire its OTC brands. Like P&G, Marico has been scouting for acuqitions in domestic market for quite some time. Chaitanya Deshmukh, head of Mergers &Acquisitions, Marico said, As you might expect, Marico cannot either confirm or deny queries on this.